yep, pretty bad at 26weeks but they staggered treatments and have 9month data for 1 group which they didn't report. investor conf this evening at 7pm pst by my calculations




NTCELL Clinical Study results to be announced on Friday 10 November

Results of NTCELL® Clinical Study in Parkinson’s

Results released to ASX on Friday 10 November
Company to host conference call on Friday 10 November at 2:00pm AEST / 4:00pm NZT

LCT has announced a trading halt ahead of the announcement of the results of the Phase IIb clinical study of NTCELL in Parkinson's disease on Friday 10 November.

Investor call

LCT CEO Ken Taylor and Principal Investigator Dr Barry Snow will host an investor call to discuss the results of the Phase IIb clinical study of NTCELL in Parkinson's disease on the day of the announcement.

Date: Friday 10 November 2017
Time: NZT 4:00pm, AEST 2:00pm

Conference ID: 3389168

Toll-free dial-in numbers for participants:
Australia - 1800 123 296
New Zealand - 0800 452 782
Canada - 1855 5616 766
China - 4001 203 085
Hong - Kong 800 908 865
India - 1800 3010 6141
Japan - 0120 985 190
Singapore - 800 616 2288
United Kingdom - 0808 234 0757
United States - 1855 293 1544
or
toll +61 2 8038 5221